Stocks and Investing
Stocks and Investing
Fri, August 3, 2018
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, August 2, 2018
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Liana Moussatos Maintained (UTHR) at Buy with Increased Target to $253 on, Aug 2nd, 2018
Liana Moussatos of Wedbush, Maintained "United Therapeutics Corporation" (UTHR) at Buy with Increased Target from $234 to $253 on, Aug 2nd, 2018.
Liana has made no other calls on UTHR in the last 4 months.
There are 2 other peers that have a rating on UTHR. Out of the 2 peers that are also analyzing UTHR, 1 agrees with Liana's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- M. Auster of "Credit Suisse" Maintained at Hold with Increased Target to $107 on, Tuesday, July 10th, 2018
This is the rating of the analyst that currently disagrees with Liana
- Geoff Meacham of "Barclays" Maintained at Sell with Decreased Target to $95 on, Thursday, May 3rd, 2018